| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Cellular and Molecular Physiology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania 17033 [L. M. B., D. E. R., S. R. R.], and Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262 [A. M. M.]
In small mammals, partial pneumonectomy (PNX) elicits rapid hyperplastic compensatory growth of the remaining lung parenchyma to restore normal lung mass, structure, and function. In BALB mice subjected to PNX, compensatory lung growth is complete within 10 days. Because cellular hyperplasia contributes to the mechanism of tumor promotion by butylated hydroxytoluene (BHT), we hypothesized that hyperplastic compensatory lung growth would promote tumor formation in carcinogen-treated animals in a manner similar to that observed after BHT. In mice subjected to PNX, within 1 week of treatment with the carcinogen 3-methylcholanthrene (MCA; 10 µg/g body weight), lung tumor multiplicity was 37-fold higher in animals subjected to PNX than in mice subjected to a sham operation. The increase in tumor multiplicity occurred when PNX was performed 1, 3, and 6 days before or 1 day after MCA treatment. In the absence of PNX, lung tumor multiplicity in MCA-treated mice given one injection of BHT (200 mg/kg body weight) increased significantly (P < 0.01) as compared to that in mice given MCA alone. Tumor multiplicity continued to increase linearly (R2 = 0.99) with each subsequent BHT injection. Lung tumor multiplicity and tumor size in mice given one or two injections of BHT were comparable to those in animals subjected to PNX. These data demonstrate that post-PNX compensatory lung growth stimulates tumorigenesis in MCA-treated mice and provides a novel model for investigating tumor formation.
This article has been cited by other articles:
![]() |
R. D. Nolen-Walston, C. F. Kim, M. R. Mazan, E. P. Ingenito, A. M. Gruntman, L. Tsai, R. Boston, A. E. Woolfenden, T. Jacks, and A. M. Hoffman Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1158 - L1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. W. Hsia Quantitative morphology of compensatory lung growth Eur. Respir. Rev., December 1, 2006; 15(101): 148 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bauer, D. Dixon, L. M. DeGraff, H.-Y. Cho, C. R. Walker, A. M. Malkinson, and S. R. Kleeberger Toll-Like Receptor 4 in Butylated Hydroxytoluene-Induced Mouse Pulmonary Inflammation and Tumorigenesis J Natl Cancer Inst, December 7, 2005; 97(23): 1778 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mae, T. P. O'Connor, and R. G. Crystal Gene Transfer of the Vascular Endothelial Growth Factor Receptor flt-1 Suppresses Pulmonary Metastasis Associated with Lung Growth Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 629 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. W. Hsia Signals and mechanisms of compensatory lung growth J Appl Physiol, November 1, 2004; 97(5): 1992 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Voswinckel, V. Motejl, A. Fehrenbach, M. Wegmann, T. Mehling, H. Fehrenbach, and W. Seeger Characterisation of post-pneumonectomy lung growth in adult mice Eur. Respir. J., October 1, 2004; 24(4): 524 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
Mechanisms and Limits of Induced Postnatal Lung Growth Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 319 - 343. [Full Text] [PDF] |
||||
![]() |
R. Voswinckel, T. Ziegelhoeffer, M. Heil, S. Kostin, G. Breier, T. Mehling, R. Haberberger, M. Clauss, A. Gaumann, W. Schaper, et al. Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth Circ. Res., August 22, 2003; 93(4): 372 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Brown, D. R. Welch, D. E. Rannels, and S. R. Rannels Partial Pneumonectomy Enhances Melanoma Metastasis to Mouse Lungs Chest, March 1, 2002; 121(2007): 28S - 29S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |